WHO ICTRP trial
A Phase 2 Double-blind, Randomized, Controlled Trial to Assess the Safety and…
TCTR20220804007 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20220804007 |
|---|---|
| Public title | A Phase 2 Double-blind, Randomized, Controlled Trial to Assess the Safety and Immunogenicity of 10 mcg HXP-GPOVac Vaccine in Healthy Volunteers |
| Scientific title | A Phase 2 Double-blind, Randomized, Controlled Trial to Assess the Safety and Immunogenicity of 10 mcg HXP-GPOVac Vaccine in Healthy Volunteers |
| Primary sponsor | The Government Pharmaceutical Organization |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Thailand |
| Conditions | Healthy male and female subjects Healthy male and female subjects;Healthy male and female subjects |
| Interventions | HXP-GPOVac vaccine 10 mcg IM (2 doses on Day 1 and Day 29),Comirnaty vaccine IM (2 doses on Day 1 and Day 29);Active Comparator Biological/Vaccine,Active Comparator Biological/Vaccine;HXP-GPOVac,Comirnaty |
| Registration date | Apr 8, 2022 |
| Target size | 300 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: